100 related articles for article (PubMed ID: 21136045)
1. 3-Deoxygalactosone, a new glucose degradation product in peritoneal dialysis fluids: identification, quantification by HPLC/DAD/MSMS and its pathway of formation.
Mittelmaier S; Fünfrocken M; Fenn D; Pischetsrieder M
Anal Bioanal Chem; 2011 Feb; 399(4):1689-97. PubMed ID: 21136045
[TBL] [Abstract][Full Text] [Related]
2. Structure- and concentration-specific assessment of the physiological reactivity of α-dicarbonyl glucose degradation products in peritoneal dialysis fluids.
Distler L; Georgieva A; Kenkel I; Huppert J; Pischetsrieder M
Chem Res Toxicol; 2014 Aug; 27(8):1421-30. PubMed ID: 25033248
[TBL] [Abstract][Full Text] [Related]
3. Quantification of reactive carbonyl compounds in icodextrin-based peritoneal dialysis fluids by combined UHPLC-DAD and -MS/MS detection.
Gensberger-Reigl S; Huppert J; Pischetsrieder M
J Pharm Biomed Anal; 2016 Jan; 118():132-138. PubMed ID: 26540628
[TBL] [Abstract][Full Text] [Related]
4. Chemical and physiological relevance of glucose degradation products in peritoneal dialysis.
Mittelmaier S; Niwa T; Pischetsrieder M
J Ren Nutr; 2012 Jan; 22(1):181-5. PubMed ID: 22200439
[TBL] [Abstract][Full Text] [Related]
5. Qualitative Profiling of Polyglucose Degradation Products in Peritoneal Dialysis Fluids.
Gensberger S; Knabner C; Waibel R; Huppert J; Pischetsrieder M
Anal Chem; 2015 Jun; 87(12):6103-11. PubMed ID: 25970747
[TBL] [Abstract][Full Text] [Related]
6. Identification and quantification of the glucose degradation product glucosone in peritoneal dialysis fluids by HPLC/DAD/MSMS.
Mittelmaier S; Fünfrocken M; Fenn D; Fichert T; Pischetsrieder M
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(11-12):877-82. PubMed ID: 20189892
[TBL] [Abstract][Full Text] [Related]
7. Quantification of the six major α-dicarbonyl contaminants in peritoneal dialysis fluids by UHPLC/DAD/MSMS.
Mittelmaier S; Fünfrocken M; Fenn D; Berlich R; Pischetsrieder M
Anal Bioanal Chem; 2011 Sep; 401(4):1183-93. PubMed ID: 21725830
[TBL] [Abstract][Full Text] [Related]
8. Identification of [6-Hydroxy-2-(hydroxymethyl)-5-oxo-5,6-dihydro-2 H-pyran-3-yl]-cysteine (HHPC) as a Cysteine-specific Modification Formed from 3,4-Dideoxyglucosone-3-ene (3,4-DGE).
Gensberger-Reigl S; Atzenbeck L; Göttler A; Pischetsrieder M
Chem Res Toxicol; 2019 Feb; 32(2):304-311. PubMed ID: 30640474
[TBL] [Abstract][Full Text] [Related]
9. 3-deoxygalactosone, a "new" 1,2-dicarbonyl compound in milk products.
Hellwig M; Degen J; Henle T
J Agric Food Chem; 2010 Oct; 58(19):10752-60. PubMed ID: 20822095
[TBL] [Abstract][Full Text] [Related]
10. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis.
Linden T; Cohen A; Deppisch R; Kjellstrand P; Wieslander A
Kidney Int; 2002 Aug; 62(2):697-703. PubMed ID: 12110035
[TBL] [Abstract][Full Text] [Related]
11. Degradation and de novo formation of nine major glucose degradation products during storage of peritoneal dialysis fluids.
Gensberger-Reigl S; Weigel I; Stützer J; Auditore A; Nikolaus T; Pischetsrieder M
Sci Rep; 2022 Mar; 12(1):4268. PubMed ID: 35277529
[TBL] [Abstract][Full Text] [Related]
12. Metal cations promote α-dicarbonyl formation in glucose-containing peritoneal dialysis fluids.
Gensberger-Reigl S; Auditore A; Huppert J; Pischetsrieder M
Glycoconj J; 2021 Jun; 38(3):319-329. PubMed ID: 33283256
[TBL] [Abstract][Full Text] [Related]
13. Identification and quantification of glucose degradation products in heat-sterilized glucose solutions for parenteral use by thin-layer chromatography.
Leitzen S; Vogel M; Engels A; Zapf T; Brandl M
PLoS One; 2021; 16(7):e0253811. PubMed ID: 34214128
[TBL] [Abstract][Full Text] [Related]
14. How to avoid glucose degradation products in peritoneal dialysis fluids.
Erixon M; Wieslander A; Lindén T; Carlsson O; Forsbäck G; Svensson E; Jönsson JA; Kjellstrand P
Perit Dial Int; 2006; 26(4):490-7. PubMed ID: 16881345
[TBL] [Abstract][Full Text] [Related]
15. PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization.
Erixon M; Lindén T; Kjellstrand P; Carlsson O; Ernebrant M; Forsbäck G; Wieslander A; Jönsson JA
Perit Dial Int; 2004; 24(4):392-8. PubMed ID: 15335155
[TBL] [Abstract][Full Text] [Related]
16. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids.
Schalkwijk CG; Posthuma N; ten Brink HJ; ter Wee PM; Teerlink T
Perit Dial Int; 1999; 19(4):325-33. PubMed ID: 10507813
[TBL] [Abstract][Full Text] [Related]
17. 3,4-DGE is important for side effects in peritoneal dialysis what about its role in diabetes.
Ortiz A; Wieslander A; Linden T; Santamaria B; Sanz A; Justo P; Sanchez-Niño MD; Benito A; Kjellstrand P
Curr Med Chem; 2006; 13(22):2695-702. PubMed ID: 17017920
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Degradation Products Formed during Heat Sterilization of Glucose Solutions by LC-MS/MS: Impact of Autoclaving Temperature and Duration on Degradation.
Leitzen S; Vogel M; Steffens M; Zapf T; Müller CE; Brandl M
Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832903
[TBL] [Abstract][Full Text] [Related]
19. Analysis of sugar degradation products with α-dicarbonyl structure in carbonated soft drinks by UHPLC-DAD-MS/MS.
Gensberger S; Glomb MA; Pischetsrieder M
J Agric Food Chem; 2013 Oct; 61(43):10238-45. PubMed ID: 23452313
[TBL] [Abstract][Full Text] [Related]
20. Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis.
Tauer A; Bender TO; Fleischmann EH; Niwa T; Jörres A; Pischetsrieder M
Mol Nutr Food Res; 2005 Jul; 49(7):710-5. PubMed ID: 15915443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
